Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
9715 transcosmos
- 3455
- -5-0.14%
20min DelayMarket Closed Dec 16 15:30 JST
151.55BMarket Cap13.69P/E (Static)
3485High3455Low38.30KVolume3470Open3460Pre Close132.69MTurnover365052wk High0.18%Turnover Ratio43.86MShares285052wk Low246.55EPS TTM73.05BFloat Cap4975Historical High13.69P/E (Static)21.14MShs Float432Historical Low252.44EPS LYR0.87%Amplitude81.00Dividend TTM1.14P/B100Lot Size2.34%Div YieldTTM
transcosmos Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.40%91.08B | -3.11%362.2B | -7.12%90.83B | -1.43%91.32B | 1.07%91.1B | -4.62%88.95B | 5.58%373.83B | 2.02%97.79B | 2.78%92.65B | 4.75%90.13B |
| Cost of revenue | 1.00%73.71B | -1.13%293.95B | -6.06%73.03B | -1.29%74.09B | 1.85%73.84B | 1.36%72.98B | 7.60%297.31B | 3.45%77.75B | 8.22%75.06B | 6.50%72.5B |
| Gross profit | 8.82%17.38B | -10.81%68.25B | -11.21%17.8B | -2.03%17.23B | -2.12%17.26B | -24.89%15.97B | -1.62%76.52B | -3.17%20.05B | -15.38%17.59B | -1.91%17.63B |
| Operating expense | 4.27%14.33B | 6.66%56.78B | 7.79%15.08B | 9.72%14.31B | 6.05%13.64B | 3.08%13.74B | 2.50%53.23B | -0.14%13.99B | 5.26%13.05B | -0.30%12.86B |
| Operating profit | 36.93%3.04B | -50.73%11.48B | -55.11%2.72B | -35.79%2.92B | -24.15%3.62B | -71.95%2.22B | -9.89%23.29B | -9.51%6.06B | -45.88%4.54B | -5.99%4.77B |
| Net non-operating interest income (expenses) | -15.38%22M | 6.31%118M | -13.21%46M | 23.53%21M | -19.35%25M | 160.00%26M | 458.06%111M | 253.33%53M | 254.55%17M | 321.43%31M |
| Non-operating interest income | 41.51%75M | 44.62%282M | 29.49%101M | 59.46%59M | 38.00%69M | 76.67%53M | 54.76%195M | 13.04%78M | 60.87%37M | 138.10%50M |
| Non-operating interest expense | 96.30%53M | 95.24%164M | 120.00%55M | 90.00%38M | 131.58%44M | 35.00%27M | -46.50%84M | -53.70%25M | -41.18%20M | -45.71%19M |
| Net investment income | -10.88%680M | 253.50%1.11B | 563.39%743M | -36.80%-487M | 49.18%91M | 53.52%763M | 39.56%314M | -70.53%112M | -257.52%-356M | 141.50%61M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -2,504.35%-553M | 872.30%2.7B | -768.57%-304M | 1,199.59%3.17B | -367.14%-187M | 2,400.00%23M | -56.01%278M | -131.25%-35M | 110.34%244M | -85.83%70M |
| Income from associates and other participating interests | -109.66%-17M | 138.32%558M | 63.20%-138M | 173.28%288M | 145.22%232M | 200.57%176M | -133.43%-1.46B | -111.24%-375M | -174.83%-393M | -142.54%-513M |
| Special income (charges) | 757.14%46M | -228.65%-220M | -43.48%-99M | -55.65%-193M | -77.30%79M | -143.75%-7M | -57.25%171M | 24.18%-69M | 32.97%-124M | -51.87%348M |
| Less:Other special charges | -283.33%-46M | 128.64%118M | 1,166.67%38M | 523.81%178M | 75.64%-86M | 40.00%-12M | 14.88%-412M | -95.52%3M | -124.56%-42M | 51.44%-353M |
| Less:Write off | ---- | -57.68%102M | -7.58%61M | -90.96%15M | 40.00%7M | 375.00%19M | 186.90%241M | 175.00%66M | 1,085.71%166M | 25.00%5M |
| Other non-operating income (expenses) | -57.65%36M | -14.84%620M | -39.57%307M | 72.58%107M | 44.05%121M | 14.86%85M | 321.95%728M | 1,158.33%508M | 122.63%62M | 154.19%84M |
| Income before tax | -0.97%3.26B | -30.18%16.36B | -47.68%3.27B | 45.87%5.82B | -17.95%3.98B | -60.58%3.29B | -24.64%23.44B | -39.89%6.25B | -50.83%3.99B | -32.47%4.85B |
| Income tax | -13.80%1.32B | -19.16%5.22B | 596.27%1.12B | 6.19%1.73B | -53.96%836M | -46.29%1.53B | -22.54%6.46B | -93.75%161M | -37.64%1.63B | -8.10%1.82B |
| Net income | 10.11%1.94B | -34.38%11.14B | -64.71%2.15B | 73.19%4.09B | 3.62%3.15B | -67.98%1.76B | -25.41%16.98B | -22.12%6.09B | -57.10%2.36B | -41.74%3.04B |
| Net income continuous operations | 10.17%1.94B | -34.38%11.14B | -64.71%2.15B | 73.31%4.09B | 3.59%3.15B | -67.98%1.76B | -25.41%16.98B | -22.12%6.09B | -57.11%2.36B | -41.72%3.04B |
| Noncontrolling interests | 12.71%328M | -13.78%1.05B | -22.41%232M | -5.11%297M | -14.12%225M | -13.91%291M | -5.02%1.21B | -1.97%299M | 5.39%313M | -19.14%262M |
| Net income attributable to the company | 9.67%1.61B | -35.96%10.1B | -66.90%1.92B | 85.30%3.79B | 5.30%2.92B | -71.54%1.47B | -26.62%15.77B | -22.93%5.79B | -60.68%2.05B | -43.25%2.77B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 9.67%1.61B | -35.96%10.1B | -66.90%1.92B | 85.30%3.79B | 5.30%2.92B | -71.54%1.47B | -26.62%15.77B | -22.93%5.79B | -60.68%2.05B | -43.25%2.77B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 10.84%43.44 | -30.77%269.46 | -65.06%51.14 | 96.16%101.2 | 16.56%77.93 | -68.50%39.19 | -24.88%389.22 | -19.17%146.36 | -58.90%51.59 | -43.25%66.86 |
| Diluted earnings per share | 10.80%40.64 | -31.14%252.44 | -65.22%47.89 | 95.57%94.85 | 15.85%73.02 | -68.75%36.68 | -28.02%366.6 | -20.64%137.71 | -61.36%48.5 | -46.50%63.03 |
| Dividend per share | 0 | -30.77%81 | -30.77%81 | 0 | 0 | 0 | -25.00%117 | -25.00%117 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |